Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose dexmedetomidine and postoperative delirium in elderly hip surgery
TCTR20221004001Phase 3Completed
- Sponsor
- Maharat Nakhon Ratchasima Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in postoperative delirium (POD), sponsored by Maharat Nakhon Ratchasima Hospital. Started Oct 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on TCTR20221004001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221004001.